[Federal Register Volume 68, Number 116 (Tuesday, June 17, 2003)]
[Notices]
[Pages 35917-35918]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-15200]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By notice dated January 27, 2003, and published in the Federal 
Register on February 6, 2003 (68 FR 6183), Lipomed, Inc., One Broadway, 
Cambridge, Massachusetts 02142, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
basic class of controlled substances listed below:

------------------------------------------------------------------------
                       Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).................................  I
Methaqualone (2565)..............................  I
Lysergic acide diethylamide (7315)...............  I
Marihuana (7360).................................  I
Tetrahydrocannabinols (7307).....................  I
Mescaline (7381).................................  I
3,4,5-Trimethoxyamphetamine (7391)...............  I
4-Bromo-2,5-dimethoxyamphetamine (7391)..........  I
4-Methyl-2,5-dimethoxyamphetamine (7395).........  I

[[Page 35918]]

 
2,5-Dimethoxyamphetamine (7396)..................  I
2,5-Dimethoxy-4-ethylamphetamine (7399)..........  I
3,4-Methylenedioxyamphetamine (7400).............  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....  I
3,4-Methylenedioxymethamphetamine (7405).........  I
Psilocybin (7437)................................  I
Psilocyn (7438)..................................  I
Acetyldihydrocodeine (9051)......................  I
Dihydromorphine (9145)...........................  I
Heroin (9200)....................................  I
Tilidine (9750)..................................  I
Amphetamie (1100)................................  II
Methamphetamine (1105)...........................  II
Amobarbital (2125)...............................  II
Secobarbital (2315)..............................  II
Phencyclidine (7471).............................  II
Cocaine (9041)...................................  II
Codeine (9050)...................................  II
Dihydrocodeine (9120)............................  II
Oxycodone (9143).................................  II
Hydromorphone (9150).............................  II
Benzoylecgonine (9180)...........................  II
Hydrocodone (9193)...............................  II
Levorphanol (9220)...............................  II
Methadone (9250).................................  II
Dextrophrpoxyphene, bulk (non-dosage forms)        II
 (9273).
Morphine (9300)..................................  II
Thebaine (9333)..................................  II
Oxymorphone (9652)...............................  II
Alfentanil (9737)................................  II
Fentanyl (9801)..................................  II
------------------------------------------------------------------------

    The firm plans to import small reference standard quantities of 
finished commercial product from its sister company in Switzerland for 
sale to its customers for drug testing.
    No comments or objections have been received. DEA has considered 
the factors in title 21, United States Code, section 823(a) and 
determined that the registration of Lipomed, Inc. to import the listed 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Lipomed, Inc. on a regular basis to ensure that the company's continued 
registration is consistent with the public interest. This investigation 
included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to section 1008(a) of the Controlled Substances Import and 
Export Act and in accordance with title 21, Code of Federal 
Regulations, section 1301.34, the above firm is granted registration as 
an importer of the basic classes of controlled substances listed above.

    Dated: June 6, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-15200 Filed 6-16-03; 8:45 am]
BILLING CODE 4410-09-M